Provided by Tiger Trade Technology Pte. Ltd.

Caribou Biosciences

2.14
+0.220011.46%
Post-market: 2.150.0056+0.26%17:39 EST
Volume:4.61M
Turnover:9.87M
Market Cap:200.02M
PE:-1.26
High:2.22
Open:1.90
Low:1.87
Close:1.92
52wk High:3.54
52wk Low:0.6600
Shares:93.47M
Float Shares:84.06M
Volume Ratio:3.64
T/O Rate:5.49%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.6979
EPS(LYR):-1.6509
ROE:-74.28%
ROA:-32.41%
PB:1.41
PE(LYR):-1.30

Loading ...

Caribou Biosciences (CRBU) Receives a Buy from Citi

TIPRANKS
·
Feb 20

Caribou Biosciences to Participate in Citi Virtual Oncology Leadership Summit

Reuters
·
Feb 13

Caribou Biosciences Showcases Promising Phase 1 CAR-T Cell Therapy Data at 2026 Tandem Meetings

Reuters
·
Feb 04

Caribou Biosciences Initiated at Buy by Clear Street

Dow Jones
·
Feb 03

Caribou Biosciences Inc : Bofa Global Research Cuts Price Objective to $6 From $8

THOMSON REUTERS
·
Jan 07

BofA Adjusts Price Target on Caribou Biosciences to $6 From $8, Maintains Buy Rating

MT Newswires Live
·
Jan 06

Performance Shipping And 2 Other Promising Penny Stocks For Your Consideration

Simply Wall St.
·
Dec 06, 2025

Caribou Biosciences Hosts KOL Panel on Allogeneic CAR-T Access at ASH Annual Meeting

Reuters
·
Dec 02, 2025

Caribou Biosciences to Host In-Person and Virtual KOL Event at ASH 2025

GlobeNewswire
·
Dec 02, 2025

Caribou Biosciences Q3 Licensing And Collaboration Revenue USD 2.198 Million

Reuters
·
Nov 20, 2025

ADVISORY-Alert wrongly tagged to Caribou Biosciences withdrawn

Reuters
·
Nov 18, 2025

Former Amazon and PepsiCo Leader Chris Winkler Joins Caribou as Svp, Revenue & Operations

THOMSON REUTERS
·
Nov 18, 2025

Caribou Biosciences: Promising Financials and Clinical Success Drive Buy Rating

TIPRANKS
·
Nov 17, 2025

Caribou Biosciences (CRBU) Receives a Buy from RBC Capital

TIPRANKS
·
Nov 13, 2025

Caribou Biosciences Q3 EPS $(0.30) Beats $(0.36) Estimate, Sales $2.198M Miss $2.650M Estimate

Benzinga
·
Nov 13, 2025

Caribou Biosciences reports third quarter revenue of $2.2 million

Reuters
·
Nov 13, 2025

BRIEF-Caribou Biosciences Q3 Licensing And Collaboration Revenue USD 2.198 Million

Reuters
·
Nov 13, 2025

Top News Today/Canada: Barrick's Interim CEO Gets to Work

Dow Jones
·
Nov 11, 2025

Caribou Biosciences Is Maintained at Buy by HC Wainwright & Co.

Dow Jones
·
Nov 05, 2025

Caribou Biosciences to Participate in Upcoming Investor Conferences

GlobeNewswire
·
Nov 04, 2025